InvestorsHub Logo
Followers 99
Posts 2761
Boards Moderated 2
Alias Born 02/10/2004

Re: zenvesting post# 191

Tuesday, 12/01/2015 10:51:36 AM

Tuesday, December 01, 2015 10:51:36 AM

Post# of 430
A look at the market potential for Covalon's Silvercoat Foley Catheter - The total Foley catheter market is estimated at $500M in 2015, with antimicrobial estimated to be close to $290M of that market in this Frost & Sullivan report written in 2011 and based on 2009 projections: http://www.academia.edu/7673287/U._S._Urinary_Incontinence_Devices

Interestingly, this report indicates that Medline's Silvertouch Foley catheter had reached 2% market penetration in 2009, after its 2007 introduction. As we know, that product is licensed from Covalon and I believe is substantially equivalent to the Silvercoat Foley catheter Covalon will be marketing. This white paper from Medline makes a pretty good case for it being better than the "competition": https://www.medline.com/irj/servlet/prt/portal/prtroot/pcd!3aportal_content!2fmedline!2fGlobal!2fPublicDocs/publicdocuments/Medline%20Documents/Marketing%20Materials/MarketingDocuments_N-Z/SIlvertouch%20Brochure%20MKT210104%20LIT498.pdf

I am quite optimistic about the possibilities this opens up for Covalon.

"Our houses are such unwieldy property that we are often imprisoned rather than housed in them." - Henry David Thoreau, Walden: Economy, 1854